1. Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs
   Maira Huerta-Reyes et al, 2019, Frontiers in Oncology CrossRef
2. Neoadjuvant chemotherapy modifies serum pyrrolidone carboxypeptidase specific activity in women with breast cancer and influences circulating levels of GnRH and gonadotropins
   María Jesús Ramírez-Expósito et al, 2020, Breast Cancer Research and Treatment CrossRef
3. S100A4 in cancer progression and metastasis: A systematic review
   Fei Fei et al, 2017, Oncotarget CrossRef
4. Screened peptides from one-bead one-compound technique extend half-life of peptide drugs in circulation through binding to albumin
   Yi-Jing Li et al, 2024, Chinese Chemical Letters CrossRef
5. Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling
   Johanna W. Hellinger et al, 2020, Scientific Reports CrossRef
6. The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis
   Carsten Gründker et al, 2017, Frontiers in Endocrinology CrossRef
7. Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion
   Johanna W. Hellinger et al, 2019, Frontiers in Oncology CrossRef
8. Triple-negative and triple-positive breast cancer cells reciprocally control their growth and migration via the S100A4 pathway
   Elena A. Dukhanina et al, 2022, Cell Adhesion & Migration CrossRef
9. Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4
   Lina Prasmickaite et al, 2018, Molecular Oncology CrossRef
10. Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells
    Katharina Kolb et al, 2020, Cells CrossRef